Bevacizumab for non-small-cell lung cancer

MeSH terms

• Antibodies, Monoclonal / adverse effects
• Antibodies, Monoclonal / therapeutic use*
• Antibodies, Monoclonal, Humanized
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Bevacizumab
• Carboplatin / administration & dosage
• Carcinoma, Non-Small-Cell Lung / drug therapy*
• Carcinoma, Non-Small-Cell Lung / mortality
• Hemoptysis / chemically induced*
• Hemorrhage / chemically induced
• Humans
• Lung Diseases / chemically induced
• Lung Neoplasms / drug therapy*
• Lung Neoplasms / mortality
• Paclitaxel / administration & dosage
• Risk Factors
• Survival Analysis